Chao‐Yie Yang
0000-0002-5445-0109
Publication & Citation Trends
Publications
168 total
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo PDF
Cited by 600
OpenAlex
Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer PDF
Cited by 379
OpenAlex
Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression PDF
Cited by 297
OpenAlex
Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression PDF
Cited by 357
OpenAlex
Targeting the MDM2–p53 Protein–Protein Interaction for New Cancer Therapy: Progress and Challenges PDF
Cited by 315
OpenAlex
Research Topics
Ubiquitin and proteasome pathways
(43)
Cell death mechanisms and regulation
(42)
Protein Degradation and Inhibitors
(35)
Multiple Myeloma Research and Treatments
(20)
ATP Synthase and ATPases Research
(18)
Affiliations
Argonne National Laboratory
National Institutes of Health
Advanced Micro Devices (Canada)
Howard Hughes Medical Institute
University of Tennessee Health Science Center